Under the Food and Drug Administration’s update Friday, officials said regulated cat and dog food manufacturers who sell uncooked or unpasteurized products must reanalyze food safety plans to ...
Just a few weeks ago on January 15, the Food and Drug Administration (FDA) under the Biden administration revoked authorization of the additive red dye 3, meaning it will be banned from foods and ...
With one year left to comply with the FDA's Food Traceability Rule, companies have made progress but still face challenges.
Breadcrumbs sold for months throughout the United States contain an undeclared allergen and are being recalled for safety reasons, the Food and Drug Administration announced on its website on Jan. 28.
Defense Secretary Pete Hegseth said Friday that ... one splendidly [surgical] Israeli-style 1967 surprise attack on 20 drug labs in Mexico and elsewhere, with or without the permission of those ...
The U.S. Food and Drug Administration recall has been upgraded to the highest risk factor products that might have undeclared food ingredients, including milk, soy, wheat, sesame, FD&C #6 and almonds.
Jackson 1 upheld a doctor’s conviction under Section 301(k) of the Federal Food, Drug ... 1006 “practice of medicine” defense. With DOJ and FDA now armed with two circuit opinions (Kaplan ...
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioid analgesic designed to treat moderate to ...
The US Food and Drug Administration (FDA) classified the recall as a Class I risk, the highest warning level, indicating a significant risk of serious health consequences or death. While the ...
DYNE-101 has been granted orphan drug designation by the U.S. Food and Drug Administration and the European Medicines Agency for the treatment of DM1.
The U.S. Food and Drug Administration (FDA) has granted fast track designation to DYNE-101, a treatment candidate for myotonic dystrophy type 1 (DM1) — in which disease symptoms begin during adulthood ...